ASCEND BY NTHRYS
Research Abroad Products

Molecular Endocrinology Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 200 project topics
AI-Powered Hormone Receptor Binding Prediction Platform
A machine learning platform that predicts ligand-receptor binding affinities and selectivity profiles for novel reproductive hormone compounds before synthesis. Accelerates drug candidate screening by 60% and reduces R&D costs by enabling virtual optimization of lead molecules.
Reproductive Endocrinology Drug Development Click to view more details →
High-Throughput Gonadotropin Signaling Assay Kit
A standardized, automated assay platform measuring LH and FSH receptor activation, G-protein coupling, and downstream signaling in a 384-well format. Enables pharmaceutical companies to screen 10,000+ compounds monthly, supporting $2M+ annual licensing revenue per client.
Reproductive Endocrinology Drug Development Click to view more details →
Clinical Pharmacokinetics SaaS for Steroid Hormone Drugs
A cloud-based pharmacokinetic modeling and simulation platform specialized in predicting tissue distribution, metabolism, and clearance of synthetic androgens, progestins, and estrogens. Reduces preclinical to Phase II timelines by 18 months and monetizes through tiered SaaS subscriptions ($50K-$200K annually).
Reproductive Endocrinology Drug Development Click to view more details →
Real-Time Molecular Dynamics GnRH Agonist Design Suite
A GPU-accelerated computational chemistry platform simulating GnRH receptor conformational dynamics and peptide-receptor interactions with real-time visualization. Delivers 40% faster lead optimization cycles and sells as a perpetual license plus annual support ($150K-$500K).
Reproductive Endocrinology Drug Development Click to view more details →
Biomarker Discovery Engine for Female Fertility Therapeutics
An integrated genomics and proteomics data platform identifying predictive biomarkers for ovulatory dysfunction, endometriosis, and PCOS treatment response. Enables companion diagnostic co-development, unlocking $5M+ in biomarker licensing and royalty revenue streams.
Reproductive Endocrinology Drug Development Click to view more details →
Testosterone Replacement Therapy Compliance Monitoring App
A mobile application tracking patient adherence, serum testosterone levels, and adverse event reporting for TRT clinical trials and post-market surveillance. Generates recurring revenue through $8-15 monthly per-patient licensing fees, supporting 100K+ patient monitoring capacity.
Reproductive Endocrinology Drug Development Click to view more details →
Selective Estrogen Receptor Modulator Property Prediction Engine
A specialized QSAR and deep learning platform predicting tissue-selective ER alpha/beta binding, metabolic stability, and off-target pharmacology for SERM candidates. Reduces failed clinical candidates by 35% and commands $250K annual subscription pricing per pharmaceutical partner.
Reproductive Endocrinology Drug Development Click to view more details →
In Vitro Ovarian Follicle Culture Media Optimization System
An automated bioreactor system with AI-driven media formulation and real-time metabolic monitoring for human follicle development in fertility applications. Opens direct B2B sales to fertility clinics ($200K per unit) and recurring media supply contracts ($50K+ annually).
Reproductive Endocrinology Drug Development Click to view more details →
Prolactin Pathway Modulation Drug Screening Consortium Platform
A centralized data commons and collaborative screening platform enabling multi-pharma access to standardized prolactin assays, cell models, and compound libraries. Monetizes through consortium membership fees ($300K-$1M annually) and exclusive data licensing rights.
Reproductive Endocrinology Drug Development Click to view more details →
Aromatase Inhibitor Pharmacogenomics Clinical Decision Support System
A precision medicine software integrating CYP19A1 genotypes, drug-drug interactions, and hormone level predictions to optimize AI dosing in post-menopausal women. Captures $25-40 per clinical decision supported, scaling to $2M+ annual revenue across oncology and endocrinology networks.
Reproductive Endocrinology Drug Development Click to view more details →
Real-time Cortisol Monitoring SaaS Dashboard Platform
A cloud-based clinical decision support platform that integrates continuous cortisol biosensor data with AI-driven diagnostic algorithms to detect Cushings syndrome and adrenal insufficiency in real-time. Enables pharmaceutical companies and clinicians to accelerate drug trials, reduce diagnostic delays, and establish recurring subscription revenue through enterprise licensing.
Adrenal & Pituitary Molecular Disease Platforms Click to view more details →
ACTH-Cortisol Biomarker Assay Kit Commercial Service
A proprietary high-throughput immunoassay service that delivers clinically validated ACTH and cortisol measurements with sub-hour turnaround and automated biomarker interpretation. Generates high-margin recurring revenue through lab partnerships, hospital networks, and diagnostic reference centers requiring precision endocrine testing.
Adrenal & Pituitary Molecular Disease Platforms Click to view more details →